Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Montelukast add-on to Mometasone in Asthma
NCT00666679Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- May 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of montelukast in asthma (2 arms), sponsored by Organon & Co. Primary endpoint: Change From Baseline in Forced Expiratory Volume in 1 Second at 2 weeks. Started May 2008; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00666679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666679.